Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.

Saved in:
Bibliographic Details
Title: Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.
Authors: Gensicke, H., Frih, A. A., Strbian, D., Zini, A., Pezzini, A., Padjen, V., Haueter, M., Seiffge, D. J., Mäkitie, L., Traenka, C., Poli, L., Martinez ‐ Majander, N., Putaala, J., Bonati, L. H., Sibolt, G., Giovannini, G., Curtze, S., Beslac ‐ Bumbasirevic, L., Vandelli, L., Lyrer, P. A.
Source: European Journal of Neurology. Feb2017, Vol. 24 Issue 2, p262-269. 8p.
Subjects: Proteinuria diagnosis, Stroke patients, Thrombolytic therapy, Glomerular filtration rate, Intravenous therapy, Cerebral hemorrhage, Mortality risk factors
Abstract: Background and purpose Proteinuria and estimated glomerular filtration rate ( eGFR) are indicators of renal function. Whether proteinuria better predicts outcome than eGFR in stroke patients treated with intravenous thrombolysis ( IVT) remains to be determined. Methods In this explorative multicenter IVT register based study, the presence of urine dipstick proteinuria (yes/no), reduced eGFR (<60 ml/min/1.73 m2) and the coexistence of both with regard to (i) poor 3-month outcome (modified Rankin Scale score 3-6), (ii) death within 3 months and (iii) symptomatic intracranial hemorrhage ( ECASS- II criteria) were compared. Unadjusted and adjusted odds ratios ( ORs) with 95% confidence intervals were calculated. Results Amongst 3398 patients, 881 (26.1%) had proteinuria and 623 (18.3%) reduced eGFR. Proteinuria [ ORadjusted 1.65 (1.37-2.00) and ORadjusted 1.52 (1.24-1.88)] and reduced eGFR [ ORadjusted 1.26 (1.01-1.57) and ORadjusted 1.34 (1.06-1.69)] were independently associated with poor functional outcome and death, respectively. After adding both renal markers to the models, proteinuria [ ORadjusted+eGFR 1.59 (1.31-1.93)] still predicted poor outcome whilst reduced eGFR [ ORadjusted+proteinuria 1.20 (0.96-1.50)] did not. Proteinuria was associated with symptomatic intracranial hemorrhage [ ORadjusted 1.54 (1.09-2.17)] but not reduced eGFR [ ORadjusted 0.96 (0.63-1.62)]. In 234 (6.9%) patients, proteinuria and reduced eGFR were coexistent. Such patients were at the highest risk of poor outcome [ ORadjusted 2.16 (1.54-3.03)] and death [ ORadjusted 2.55 (1.69-3.84)]. Conclusion Proteinuria and reduced eGFR were each independently associated with poor outcome and death but the statistically strongest association appeared for proteinuria. Patients with coexistent proteinuria and reduced eGFR were at the highest risk of poor outcome and death. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:Background and purpose Proteinuria and estimated glomerular filtration rate ( eGFR) are indicators of renal function. Whether proteinuria better predicts outcome than eGFR in stroke patients treated with intravenous thrombolysis ( IVT) remains to be determined. Methods In this explorative multicenter IVT register based study, the presence of urine dipstick proteinuria (yes/no), reduced eGFR (<60 ml/min/1.73 m2) and the coexistence of both with regard to (i) poor 3-month outcome (modified Rankin Scale score 3-6), (ii) death within 3 months and (iii) symptomatic intracranial hemorrhage ( ECASS- II criteria) were compared. Unadjusted and adjusted odds ratios ( ORs) with 95% confidence intervals were calculated. Results Amongst 3398 patients, 881 (26.1%) had proteinuria and 623 (18.3%) reduced eGFR. Proteinuria [ ORadjusted 1.65 (1.37-2.00) and ORadjusted 1.52 (1.24-1.88)] and reduced eGFR [ ORadjusted 1.26 (1.01-1.57) and ORadjusted 1.34 (1.06-1.69)] were independently associated with poor functional outcome and death, respectively. After adding both renal markers to the models, proteinuria [ ORadjusted+eGFR 1.59 (1.31-1.93)] still predicted poor outcome whilst reduced eGFR [ ORadjusted+proteinuria 1.20 (0.96-1.50)] did not. Proteinuria was associated with symptomatic intracranial hemorrhage [ ORadjusted 1.54 (1.09-2.17)] but not reduced eGFR [ ORadjusted 0.96 (0.63-1.62)]. In 234 (6.9%) patients, proteinuria and reduced eGFR were coexistent. Such patients were at the highest risk of poor outcome [ ORadjusted 2.16 (1.54-3.03)] and death [ ORadjusted 2.55 (1.69-3.84)]. Conclusion Proteinuria and reduced eGFR were each independently associated with poor outcome and death but the statistically strongest association appeared for proteinuria. Patients with coexistent proteinuria and reduced eGFR were at the highest risk of poor outcome and death. [ABSTRACT FROM AUTHOR]
ISSN:13515101
DOI:10.1111/ene.13179